Furthermore, a 2024 study revealed that CD8+ T-cell–derived IFN-γ promotes AAA formation in mice, suggesting that regulation of this pathway could represent a novel therapeutic direction [153]. This evidence concerns the gene CD8A and triple-A syndrome.